Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
ASP Isotopes's Sloan Ratio for the quarter that ended in Mar. 2026 was 14.37%.
As of Mar. 2026, ASP Isotopes has a Sloan Ratio of 14.37%, indicating there is a warning stage of accrual build up.
ASP Isotopes (NAS:ASPI) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, ASP Isotopes has a Sloan Ratio of 14.37%, indicating there is a warning stage of accrual build up.
ASP Isotopes Sloan Ratio % Related Terms
ASP Isotopes Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for ASP Isotopes's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, ASP Isotopes's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASP Isotopes Sloan Ratio % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, ASP Isotopes's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where ASP Isotopes's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
ASP Isotopes's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
ASP Isotopes's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was -75.063 (Jun. 2025 ) + -12.874 (Sep. 2025 ) + -78.709 (Dec. 2025 ) + -6.878 (Mar. 2026 ) = $-173.52 Mil.
ASP Isotopes's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was -7.901 (Jun. 2025 ) + -8.858 (Sep. 2025 ) + -17.851 (Dec. 2025 ) + -17.76 (Mar. 2026 ) = $-52.37 Mil.
ASP Isotopes's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was -31.749 (Jun. 2025 ) + -1.504 (Sep. 2025 ) + -75.182 (Dec. 2025 ) + -97.183 (Mar. 2026 ) = $-205.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASP Isotopes (ASPI) has a Sloan Ratio % of 14.37% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on ASP Isotopes and its competitors.
Is ASP Isotopes' Sloan Ratio % too high?
ASP Isotopes' current Sloan Ratio % is 14.37%. Overall, ASP Isotopes has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does ASP Isotopes' Sloan Ratio % compare to LXU and WLKP?
ASP Isotopes' Sloan Ratio % of 14.37% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Chemicals company?
A good Sloan Ratio % depends on the Chemicals industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on ASP Isotopes and its competitors. ASP Isotopes's current Sloan Ratio % is 14.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASP Isotopes stock overvalued right now?
ASP Isotopes (ASPI) has a current Sloan Ratio % of 14.37%. The current Sloan Ratio % is 14.37%. ASP Isotopes' overall GF Score™ is 30/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For ASP Isotopes (ASPI), the current Sloan Ratio % is 14.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
30GF Score
Get the complete analysis for ASPI
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASPI has been successfully added to your 
